EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Markers of Hepatic Insulin Clearance and Their Association With Steatosis in Hyperinsulinaemic Horses

Miranda Dosi iD, Laura Scott, Holly Payne, Jacqueline Poldy, John Keen, Bruce McGorum, Alexandra Malbon iD, Ruth Morgan iD

Journal of Veterinary Internal Medicine · 2025

DOI: 10.1111/jvim.70143 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, 2025. Written by Miranda Dosi and 7 co-authors. Institution: Scotland Rural College, Edinburgh, UK. Major MEDLINE topics: Horse Diseases, Hyperinsulinism, Insulin, Liver. Cited 1 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Hyperinsulinaemia (HI) is an important feature of Equine Metabolic Syndrome (EMS). It has been suggested that reduced hepatic clearance of insulin contributes to HI, particularly in humans affected by metabolic dysfunction-associated steatotic liver disease (MASLD). Hypothesis In obese horses with HI, insulin clearance is impaired and associated with MASLD. Animals Tissue samples were collected at post-mortem from clinically well-characterized horses with HI (n = 13; basal insulin > 20 mIU/l) and without HI (control; n = 20).

Methods

Retrospective observational study. Molecular drivers of hepatic clearance (CAECAM-1, an insulin chaperone protein and IDE-Insulin Degrading Enzyme) were quantified by RT-qPCR and activity, respectively, in liver tissue. Fixed liver sections stained with hematoxylin and eosin (H&E) were assigned a histological score by two blinded observers using an equine liver disease score and a human MASLD score. Triglyceride (TG) content in liver sections, serum liver enzymes, ACTH, basal insulin, and serum triglycerides were also measured.

Results

IDE activity was 2.73 (IQR 4.00 activity/mg of protein) in HI horses and 2.18 (IQR 0.55) in controls (p = 0.07). IDE activity correlated negatively with insulin (rho = 0.561, p = 0.04) but not with liver or serum TG. CEACAM-1 gene expression was higher in the HI group (2.09 ± 1.79 folds) than in controls (0.69 ± 0.62, p = 0.03). Liver disease and MASLD scores were no different between groups, whereas triglyceride liver content was higher in horses with HI (504.83 IQR 217.51 nmol/g) compared to controls (363.58 IQR 67.32 nmol/g, p = 0.04). Conclusions and Clinical Relevance MASLD is not consistently present in HI horses, but CAECAM-1 expression is higher.

Subjects

MeSH terms (MEDLINE)

Horse DiseasesHyperinsulinismInsulinLiverFatty LiverAnimalsHorsesRetrospective StudiesMaleFemaleBiomarkersInsulysinTriglycerides

Author keywords

MASLDCEACAM‐1equine metabolic syndromeinsulin degrading enzyme

Substances

InsulinBiomarkersInsulysinTriglycerides

Authors and institutions

  • Scotland Rural College, Edinburgh, UK.
  • Royal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Roslin, UK.

ORCID profiles: Miranda Dosi, Alexandra Malbon, Ruth Morgan

Cite

APA

Dosi, M., Scott, L., Payne, H., Poldy, J., Keen, J., McGorum, B., Malbon, A., & Morgan, R. (2025). Markers of Hepatic Insulin Clearance and Their Association With Steatosis in Hyperinsulinaemic Horses. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70143

Vancouver

Dosi M, Scott L, Payne H, Poldy J, Keen J, McGorum B, et al. Markers of Hepatic Insulin Clearance and Their Association With Steatosis in Hyperinsulinaemic Horses. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70143

BibTeX
@article{Dosi2025,
  author = {Dosi, Miranda and Scott, Laura and Payne, Holly and Poldy, Jacqueline and Keen, John and McGorum, Bruce and Malbon, Alexandra and Morgan, Ruth},
  title = {Markers of Hepatic Insulin Clearance and Their Association With Steatosis in Hyperinsulinaemic Horses},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2025},
  doi = {10.1111/jvim.70143}
}
Start for free →